Why Copper IUDs Cause Heavy Menstrual Bleeding
Copper IUDs cause heavy menstrual bleeding through a local inflammatory response in the endometrium, triggered by copper ion release that damages tissue, increases vascular permeability through VEGF upregulation, and impairs normal endometrial repair mechanisms. 1, 2, 3
Mechanism of Bleeding
The copper ions released from the IUD create several interconnected pathological processes:
Direct Endometrial Damage and Inflammation
- Copper ion toxicity: High concentrations of Cu²⁺ in the uterine cavity cause direct endometrial tissue damage and trigger a local inflammatory cascade 2, 3
- Women with abnormal bleeding have significantly higher daily copper dissolution rates from their IUDs compared to those with normal menstruation 3
- This inflammation disrupts normal endometrial integrity, leading to increased bleeding
Vascular Changes
- VEGF upregulation: Elevated copper ion concentrations in endometrial tissue stimulate increased secretion of vascular endothelial growth factor (VEGF), which increases vascular permeability and promotes bleeding 3
- There is a direct positive correlation between endometrial copper ion concentration and VEGF expression 3
- Some studies show altered uterine artery blood flow patterns, with lower pulsatility index values associated with increased bleeding risk 4
Impaired Tissue Repair
- Copper IUD insertion upregulates miR-144-3p expression, which subsequently downregulates both damage and repair pathways 2:
- Decreases the MT/NF-κB/MMP damage pathway
- Decreases the THBS-1/TGF-β/SMAD3 repair pathway
- This creates a situation where the endometrium cannot adequately repair itself between menstrual cycles
Clinical Pattern and Management
Expected Timeline
Heavy or prolonged bleeding is most common during the first 3-6 months of Cu-IUD use and generally decreases with continued use 1. This bleeding is considered generally not harmful despite being bothersome 1.
When to Investigate Further
After the initial 3-6 month period, new onset heavy bleeding warrants evaluation for:
- Cu-IUD displacement
- Sexually transmitted infections
- Pregnancy
- New pathologic uterine conditions (polyps, fibroids) 1
Treatment Approach
If no underlying pathology is found and the patient requests treatment, use NSAIDs for 5-7 days during bleeding episodes 1, 5. Multiple studies demonstrate statistically significant reductions in menstrual blood loss with NSAIDs including:
- Indomethacin
- Mefenamic acid
- Flufenamic acid
- Diclofenac sodium 1
Important caveat: Aspirin should NOT be used as it may actually increase bleeding in some women 1.
If bleeding persists despite treatment and is unacceptable to the patient, counsel on alternative contraceptive methods and offer removal 1.
Key Clinical Pitfalls
Don't dismiss early bleeding as abnormal: Counseling patients BEFORE insertion about expected bleeding patterns significantly reduces discontinuation rates 1
Quantify the bleeding: The absolute increase is approximately 20 mL per period 6—significant but not typically dangerous. Use validated tools like PBAC scores to objectively assess 7
Consider device differences: Cu-T 380A (higher copper surface area) causes significantly more bleeding and dysmenorrhea than Cu 375, though both remain within acceptable ranges 7
Rule out bleeding disorders: In women with persistent HMB despite Cu-IUD removal or those with HMB before insertion, consider screening for underlying bleeding disorders, which are present in 10-62% of women with HMB 8, 9